World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
45248
World Ranking
5558
National Ranking
59

Sten Madsbad publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sten Madsbad sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 677 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sten Madsbad D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sten Madsbad sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sten Madsbad is affiliated with the University of Copenhagen in Denmark. Their research primarily focuses on medical fields related to endocrinology, diabetes, and metabolism.

The main fields of study include:

  • Medicine

Subfields relevant to their work consist of:

  • Endocrinology, Diabetes and Metabolism
  • Surgery
  • Physiology
  • Molecular Biology
  • Epidemiology

The research topics covered by Sten Madsbad's publications address:

  • Diabetes Treatment and Management
  • Diet and metabolism studies
  • Bariatric Surgery and Outcomes
  • Metabolism, Diabetes, and Cancer
  • Pancreatic function and diabetes
  • Liver Disease Diagnosis and Treatment
  • Pharmacology and Obesity Treatment

Frequent coauthors who have collaborated with Sten Madsbad include:

  • Jens J. Holst
  • Kirstine N. Bojsen-Møller
  • Maria S. Svane
  • Bolette Hartmann
  • Nicolai J. Wewer Albrechtsen

Publication venues where Sten Madsbad has frequently published research are:

  • Diabetes
  • Diabetes Obesity and Metabolism
  • International Journal of Obesity
  • American Journal of Physiology-Endocrinology and Metabolism
  • The Lancet Diabetes & Endocrinology

Selected recent papers include:

  • Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined, 2021, New England Journal of Medicine
  • Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial, 2024, EClinicalMedicine
  • Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial, 2023, Cardiovascular Diabetology
  • Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trial, 2022, Human Reproduction
  • Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment, 2024, JAMA Network Open

Best Publications

  • Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

    Mette Zander;Mette Zander;Sten Madsbad;Jan Lysgaard Madsen;Jens Juul Holst

  • Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.

    Mai-Britt Toft-Nielsen;Mette B. Damholt;Sten Madsbad;Linda M. Hilsted

  • Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

    Tina Vilsbøll;Thure Krarup;Carolyn F. Deacon;Sten Madsbad

  • Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

    Anthony H. Barnett;Stephen C. Bain;Paul Bouter;Bengt Karlberg

  • The Influence of GLP-1 on Glucose-Stimulated Insulin Secretion: Effects on β-Cell Sensitivity in Type 2 and Nondiabetic Subjects

    Lise L. Kjems;Jens J. Holst;Aage Vølund;Sten Madsbad

  • 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    Carel W le Roux;Carel W le Roux;Arne Astrup;Ken Fujioka;Frank Greenway

  • Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes

    Tina Vilsbøll;Milan Zdravkovic;Tu Le-Thi;Thure Krarup

  • Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Tina Vilsbøll;T Krarup;J Sonne;S Madsbad

  • Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.

    Tina Vilsbøll;T Krarup;S Madsbad;Jens Møller Holst

  • Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.

    P. V. Højberg;P. V. Højberg;T. Vilsbøll;R. Rabøl;F. K. Knop

  • Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.

    Tina Vilsbøll;Thure Krarup;Sten Madsbad;Jens Juul Holst

  • Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?

    Filip K. Knop;Tina Vilsbøll;Patricia V. Højberg;Steen Larsen

  • Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.

    C Orskov;J Jeppesen;S Madsbad;J J Holst

  • Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.

    Sten Madsbad;Ole Schmitz;Jonas Ranstam;Grethe Jakobsen

  • Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

    M B Toft-Nielsen;S Madsbad;J J Holst

  • Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance

    N. B. Jørgensen;N. B. Jørgensen;S. H. Jacobsen;S. H. Jacobsen;C. Dirksen;C. Dirksen;K. N. Bojsen-Møller;K. N. Bojsen-Møller

  • Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease: A Population-Based Study

    Jørgen Jeppesen;Tine W. Hansen;Susanne Rasmussen;Hans Ibsen

  • Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects

    S. H. Jacobsen;S. C. Olesen;C. Dirksen;N. B. Jørgensen

  • Low birthweight is associated with specific changes in muscle insulin-signalling protein expression

    S. E. Ozanne;C. B. Jensen;K. J. Tingey;H. Storgaard

  • Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery

    Sten Madsbad;Carsten Dirksen;Jens J Holst

Frequent Co-Authors

Jens J. Holst
Jens J. Holst University of Copenhagen
Allan Vaag
Allan Vaag Steno Diabetes Center
Oluf Pedersen
Oluf Pedersen University of Copenhagen
Filip K. Knop
Filip K. Knop University of Copenhagen
Torben Hansen
Torben Hansen University of Copenhagen
Carolyn F. Deacon
Carolyn F. Deacon University of Copenhagen
Arne Astrup
Arne Astrup Novo Nordisk Foundation
Torben Jørgensen
Torben Jørgensen University of Copenhagen
Jens F. Rehfeld
Jens F. Rehfeld University of Copenhagen
Knut Borch-Johnsen
Knut Borch-Johnsen Aarhus University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in alternative pathways within healthcare or looking to advance your medical education, a range of flexible online degrees are available. For registered nurses wanting to move forward without traditional in-person requirements, rn to bsn programs without clinicals let you earn a BSN from home—ideal for working professionals.

Those with a Master of Science in Nursing who wish to pursue the highest level of practice can consider the fastest msn to dnp program. These programs let experienced nurses earn a Doctor of Nursing Practice degree in less time than traditional routes.

For learners who prefer a streamlined curriculum, there are also dnp programs without dissertation. These courses focus more on clinical skills and real-life application than academic research, making them highly practical.

If you want to start your healthcare career quickly, fast track lpn programs offer rapid entry into the workforce, providing essential medical training in an accelerated online format. These all represent valuable options if you are exploring diverse medical or nursing career paths in the USA.

Best Scientists Citing Sten Madsbad

Trending Scientists

Recently Published Articles